CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhodes, S. G.
Right arrow Articles by Vordermeier, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhodes, S. G.
Right arrow Articles by Vordermeier, H. M.
Clinical and Diagnostic Laboratory Immunology, November 2003, p. 1129-1135, Vol. 10, No. 6
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.6.1129-1135.2003

1,25-Dihydroxyvitamin D3 and Development of Tuberculosis in Cattle

S. G. Rhodes,1 L. A. Terry,2 J. Hope,3 R. G. Hewinson,1 and H. M. Vordermeier1*

TB Research Group,1 TSE Molecular Biology Group, Veterinary Laboratories Agency, Addlestone, Surrey KT15 3NB,2 Institute for Animal Health, Compton, Berkshire RG20 7NN, United Kingdom3

Received 2 April 2003/ Returned for modification 23 May 2003/ Accepted 23 July 2003

This report describes the presence and activity of 1,25-dihydroxyvitamin D3 (1,25-D3) in experimental bovine tuberculosis. Animals that went on to develop tuberculous lesions exhibited a rapid transient increase in serum 1,25-D3 within the first 2 weeks following infection with Mycobacterium bovis. 1,25-D3-positive mononuclear cells were later identified in all tuberculous granulomas by immunohistochemical staining of postmortem lymph node tissue. These results suggest a role for 1,25-D3 both at the onset of infection and in the development of the granuloma in these infected animals. Using a monoclonal antibody to the vitamin D receptor (VDR) as a VDR agonist, we confirmed that activation of the vitamin D pathway profoundly depresses antigen-specific, but not mitogenic, bovine peripheral blood T-cell responses (proliferation and gamma interferon production). Investigation of the mechanism of this suppression showed that the VDR antibody modified the expression of CD80 by accessory cells, such that a significant positive correlation between T-cell proliferation and accessory cell CD80 emerged.


* Corresponding author. Mailing address: TB Research, Veterinary Laboratories Agency, Addlestone, Surrey KT15 3NB, United Kingdom. Phone: 01932-357458. Fax: 1932-357684. E-mail: mvordermeier.vla{at}gtnet.gov.uk.


Clinical and Diagnostic Laboratory Immunology, November 2003, p. 1129-1135, Vol. 10, No. 6
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.6.1129-1135.2003




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.